3[1]Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A,1998,95(20):11891-11896. 被引量：1
4[2]Niklinska W, Chyczeuski L, Laudanski J, et al. Detection of p16 abnormality in early stage non-small celllung cancer. Folia HistochemCytobiol,2001,39 Suppl 2:30-32. 被引量：1
5[4]Kashiwabara K, Oyama T, Sano T, et al. Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers. Int J Cancer,1998,79(3):215-220. 被引量：1
6[5]Kurakawa E, Shimamoto T, Utsumi K, et al. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Int J Oncol,2001,19(2):277-281. 被引量：1
7[7]Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A,1996,93(18):9821-9826. 被引量：1
8[9]Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science,1994,264(5157):436-440. 被引量：1
9[10]Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature,1993,366(6456):704-707. 被引量：1
10[11]Gazzeri S, Gouyer V, Vour'ch C, et al. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene,1998,16(4):497-504. 被引量：1
